Education
About Us
Working with TipRanks
Follow Us
HAVN Life Sciences (DE:5NP0)
FRANKFURT:5NP0
5NP0 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.01 - €0.01
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$492.12K
Enterprise ValueN/A
Total Cash (Recent Filing)C$0.00
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.96
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding25,646,020
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
5NP0 FAQ
What was HAVN Life Sciences’s price range in the past 12 months?
HAVN Life Sciences lowest stock price was €0.01 and its highest was €0.01 in the past 12 months.
What is HAVN Life Sciences’s market cap?
HAVN Life Sciences’s market cap is $492.12K.
When is HAVN Life Sciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were HAVN Life Sciences’s earnings last quarter?
Currently, no data Available
Is HAVN Life Sciences overvalued?
According to Wall Street analysts HAVN Life Sciences’s price is currently Overvalued.
Does HAVN Life Sciences pay dividends?
HAVN Life Sciences does not currently pay dividends.
What is HAVN Life Sciences’s EPS estimate?
HAVN Life Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HAVN Life Sciences have?
HAVN Life Sciences has 25,646,020 shares outstanding.
What happened to HAVN Life Sciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of HAVN Life Sciences?
Currently, no hedge funds are holding shares in DE:5NP0
---
Company Description
HAVN Life Sciences
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.
---
Technical Analysis
Numinus Wellness
―
Cybin
―
Red Light Holland
―
Psyched Wellness
―
Entheon Biomedical
―
---